Pasar al contenido principal

UTILIDAD DEL ESTUDIO GENETICO COMO PREDICTOR DE RESPUESTA A LA CIRUGIA BARIATRICA: ESTUDIO DE COHORTES Y MECANISMOS IMPLICADOS.

PI18/00964

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO INV. BIOMEDICA DE LLEIDA. FUNDACION DR. PIFARRE (IRBLLEIDA)
Centro realización INSTITUTO INV. BIOMEDICA DE LLEIDA. FUNDACION DR. PIFARRE (IRBLLEIDA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic risk score based on obesity-related genes and progression in weight loss after bariatric surgery, a 60-month follow-up study

  • Mas-Bermejo, Patricia|||0000-0003-4789-9650
  • Azcona-Granada, Natalia
  • Peña, Elionora
  • Lecube, Albert|||0000-0001-9684-0183
  • Ciudin, Andreea|||0000-0001-5622-0203
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Luna, Alexis|||0000-0003-2351-5819
  • Rigla Cros, Mercedes|||0000-0002-6691-4871
  • Arenas Solà, Concepción|||0000-0002-6489-4934
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
  • Rosa de la Cruz, Araceli|||0000-0001-6935-3785
Background: Obesity is a polygenic multifactorial disease. Recent genome-wide association studies have identified several common loci associated with obesity-related phenotypes. Bariatric surgery (BS) is the most effective long-term treatment for patients with severe obesity. The huge variability in BS outcomes between patients suggests a moderating effect of several factors, including the genetic architecture of the patients. Objective: To examine the role of a genetic risk score (GRS) based on 7 polymorphisms in 5 obesity-candidate genes (FTO, MC4R, SIRT1, LEP, and LEPR) on weight loss after BS. Setting: University hospital in Spain. Methods: We evaluated a cohort of 104 patients with severe obesity submitted to BS (Roux-en-Y gastric bypass or sleeve gastrectomy) followed up for >60 months (lost to follow-up, 19.23%). A GRS was calculated for each patient, considering the number of carried risk alleles for the analyzed genes. During the postoperative period, the percentage of excess weight loss total weight loss and changes in body mass index were evaluated. Generalized estimating equation models were used for the prospective analysis of the variation of these variables in relation to the GRS. Results: The longitudinal model showed a significant effect of the GRS on the percentage of excess weight loss (P = 1.5 × 10-5), percentage of total weight loss (P = 3.1 × 10-8), and change in body mass index (P = 7.8 × 10-16) over time. Individuals with a low GRS seemed to experience better outcomes at 24 and 60 months after surgery than those with a higher GRS. Conclusion: The use of the GRS in considering the polygenic nature of obesity seems to be a useful tool to better understand the outcome of patients with obesity after BS.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

A Clinical-Genetic Score for Predicting Weight Loss after Bariatric Surgery: The OBEGEN Study

  • Ciudin, Andreea
  • Fidilio, Enzamaria
  • Gutiérrez Carrasquilla, Liliana
  • Caixàs, Assumpta
  • Vilarrasa, Núria
  • Pellitero, Silvia
  • Simó-Servat, Andreu
  • Vilallonga, Ramón
  • Ruiz, Amador
  • de la Fuente, Maricruz
  • Luna, Alexis
  • Sánchez Peña, Enric
  • Rigla, Mercedes
  • Hernández, Cristina
  • Salas, Eduardo
  • Simó, Rafael
  • Lecube Torelló, Albert
Around 30% of the patients that undergo bariatric surgery (BS) do not reach an appropriate weight loss. The OBEGEN study aimed to assess the added value of genetic testing to clinical variables in predicting weight loss after BS. A multicenter, retrospective, longitudinal, and observational study including 416 patients who underwent BS was conducted (Clinical.Trials.gov- NCT02405949). 50 single nucleotide polymorphisms (SNPs) from 39 genes were examined. Receiver Operating Characteristic (ROC) curve analysis were used to calculate sensitivity and specificity. Satisfactory response to BS was defined as at nadir excess weight loss >50%. A good predictive model of response [area under ROC of 0.845 (95% CI 0.805–0.880), p < 0.001; sensitivity 90.1%, specificity 65.5%] was obtained by combining three clinical variables (age, type of surgery, presence diabetes) and nine SNPs located in ADIPOQ, MC4R, IL6, PPARG, INSIG2, CNR1, ELOVL6, PLIN1 and BDNF genes. This predictive model showed a significant higher area under ROC than the clinical score (p = 0.0186). The OBEGEN study shows the key role of combining clinical variables with genetic testing to increase the predictability of the weight loss response after BS. This finding will permit us to implement a personalized medicine which will be associated with a more cost-effective clinical practice.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Clinical-Genetic Score for Predicting Weight Loss after Bariatric Surgery: The OBEGEN Study

  • Ciudin, Andreea
  • Fidilio, Enzamaria
  • Gutiérrez Carrasquilla, Liliana
  • Caixàs, Assumpta
  • Vilarrasa, Núria
  • Pellitero, Silvia
  • Simó-Servat, Andreu
  • Vilallonga, Ramón
  • Ruiz, Amador
  • de la Fuente, Maricruz
  • Luna, Alexis
  • Sánchez Peña, Enric
  • Rigla, Mercedes
  • Hernández, Cristina
  • Salas, Eduardo
  • Simó, Rafael
  • Lecube Torelló, Albert
Around 30% of the patients that undergo bariatric surgery (BS) do not reach an appropriate weight loss. The OBEGEN study aimed to assess the added value of genetic testing to clinical variables in predicting weight loss after BS. A multicenter, retrospective, longitudinal, and observational study including 416 patients who underwent BS was conducted (Clinical.Trials.gov- NCT02405949). 50 single nucleotide polymorphisms (SNPs) from 39 genes were examined. Receiver Operating Characteristic (ROC) curve analysis were used to calculate sensitivity and specificity. Satisfactory response to BS was defined as at nadir excess weight loss >50%. A good predictive model of response [area under ROC of 0.845 (95% CI 0.805–0.880), p < 0.001; sensitivity 90.1%, specificity 65.5%] was obtained by combining three clinical variables (age, type of surgery, presence diabetes) and nine SNPs located in ADIPOQ, MC4R, IL6, PPARG, INSIG2, CNR1, ELOVL6, PLIN1 and BDNF genes. This predictive model showed a significant higher area under ROC than the clinical score (p = 0.0186). The OBEGEN study shows the key role of combining clinical variables with genetic testing to increase the predictability of the weight loss response after BS. This finding will permit us to implement a personalized medicine which will be associated with a more cost-effective clinical practice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of Glucose Improvement on Nocturnal Sleep Breathing Parameters in Patients with Type 2 Diabetes, The Candy Dreams Study

  • Gutiérrez-Carrasquilla, Liliana|||0000-0001-7809-3903
  • López-Cano, Carolina|||0000-0001-7458-5871
  • Sánchez, Enric|||0000-0001-7345-1601
  • Barbé, Ferran|||0000-0002-2340-8928
  • Dalmases, Mireia
  • Hernández García, Marta|||0000-0003-1237-298X
  • Campos, Angela
  • Gaeta, Anna Michaela
  • Carmona, Paola
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Lecube, Albert|||0000-0001-9684-0183
Type 2 diabetes exerts a negative impact on sleep breathing. It is unknown whether a long-term improvement in glycemic control ameliorates this effect. We conducted an interventional study with 35 patients with type 2 diabetes and obstructive sleep apnea (OSA) to explore this. At home, sleep breathing parameters were assessed at baseline and after a 4-month period in which antidiabetic therapy was intensified. Patients who decreased their body mass index ≥2kg/m 2 were excluded. Those with an HbA1c reduction ≥0.5% were considered good responders (n = 24). After the follow-up, good responders exhibited an improvement in the apnea-hypopnea index (AHI: 26-1 (95% IC: 8.6-95.0) vs. 20.0 (4.0-62.4) events/hour, p = 0.002) and in time with oxygen saturation below 90% (CT90: 13.3 (0.4-69.0) vs. 8.1 (0.4-71.2) %, p = 0.002). No changes were observed in the group of non-responders (p = 0.722 and p = 0.138, respectively). The percentage of moderate and severe OSA decreased among good responders (p = 0.040). In the wider population, the change in HbA1c correlated positively to decreases in AHI (r = 0.358, p = 0.035) and negatively to increases in the minimum arterial oxygen saturation (r = -0.386, p = 0.039). Stepwise multivariate regression analysis showed that baseline AHI and the absolute change in HbA1c independently predicted decreased AHI (R 2 = 0.496). The improvement of glycemic control exerts beneficial effects on sleep breathing parameters in type 2 diabetes, which cannot be attributed merely to weight loss.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of Type 2 Diabetes Mellitus on the Hypoxia-Inducible Factor 1-Alpha Expression. Is There a Relationship with the Clock Genes?

  • López-Cano, Carolina|||0000-0001-7458-5871
  • Gutiérrez-Carrasquilla, Liliana|||0000-0001-7809-3903
  • Barbé, Ferran|||0000-0002-2340-8928
  • Sánchez, Enric|||0000-0001-7345-1601
  • Hernández, Marta|||0000-0003-1237-298X
  • Martí, Raquel
  • Ceperuelo Mallafré, Victòria|||0000-0002-4460-9761
  • Dalmases, Mireia
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Lecube, Albert|||0000-0001-9684-0183
Limited reports exist on the relationships between regulation of oxygen homeostasis and circadian clock genes in type 2 diabetes. We examined whether the expression of Hypoxia-Inducible Factor-1α (HIF-1α) and HIF-2α relates to changes in the expression of clock genes (Period homolog proteins (PER)1, PER2, PER3, Retinoid-related orphan receptor alpha (RORA), Aryl hydrocarbon receptor nuclear translocator-like protein 1 (ARNTL), Circadian locomotor output cycles kaput (CLOCK), and Cryptochrome proteins (CRY) 1 and CRY2) in patients with type 2 diabetes. A total of 129 subjects were evaluated in this cross-sectional study (48% with diabetes). The gene expression was measured by polymerase chain reaction. The lactate and pyruvate levels were used as surrogate of the hypoxia induced anaerobic glycolysis activity. Patients with diabetes showed an increased plasma concentration of both lactate (2102.1 ± 688.2 vs. 1730.4 ± 694.4 uM/L, p = 0.013) and pyruvate (61.9 ± 25.6 vs. 50.3 ± 23.1 uM/L, p = 0.026) in comparison to controls. However, this finding was accompanied by a blunted HIF-1α expression (1.1 (0.2 to 5.0) vs. 1.7 (0.4 to 9.2) arbitrary units (AU), p ≤ 0.001). Patients with diabetes also showed a significant reduction of all assessed clock genes' expression. Univariate analysis showed that HIF-1α and almost all clock genes were significantly and negatively correlated with HbA1c concentration. In addition, positive correlations between HIF-1α and the clock genes were observed. The stepwise multivariate regression analysis showed that HbA1c and clock genes independently predicted the expression of HIF-1α. Type 2 diabetes modifies the expression of HIF-1α and clock genes, which correlates with the degree of metabolic control
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing

  • Sánchez, Enric|||0000-0001-7345-1601
  • Sapiña-Beltrán, Esther|||0000-0002-0053-266X
  • Gavaldà, Ricard
  • Barbé, Ferran|||0000-0002-2340-8928
  • Torres, Gerard|||0000-0002-1417-7320
  • Sauret, Ariadna
  • Dalmases, Mireia
  • López-Cano, Carolina|||0000-0001-7458-5871
  • Gutiérrez-Carrasquilla, Liliana|||0000-0001-7809-3903
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Fernández, Elvira|||0000-0001-5236-1762
  • Purroy, Francisco|||0000-0002-1808-5968
  • Castro-Boqué, Eva|||0000-0002-1013-0007
  • Farràs-Sallés, Cristina|||0000-0001-5956-4116
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Mauricio, Didac|||0000-0002-2868-0250
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Lecube, Albert|||0000-0001-9684-0183
Type 2 diabetes leads to severe nocturnal hypoxemia, with an increase in apnea events and daytime sleepiness. Hence, we assessed sleep breathing parameters in the prediabetes stage. A cross-sectional study conducted on 966 middle-aged subjects without known pulmonary disease (311 patients with prediabetes and 655 controls with normal glucose metabolism) was conducted. Prediabetes was defined by glycated hemoglobin (HbA1c), and a nonattended overnight home sleep study was performed. Participants with prediabetes (n = 311) displayed a higher apnea-hypopnea index (AHI: 12.7 (6.1;24.3) vs. 9.5 (4.2;19.6) events/h, p < 0.001) and hypopnea index (HI: 8.4 (4.0;14.9) vs. 6.0 (2.7;12.6) events/h, p < 0.001) than controls, without differences in the apnea index. Altogether, the prevalence of obstructive sleep apnea was higher in subjects with prediabetes than in controls (78.1 vs. 69.9%, p = 0.007). Additionally, subjects with prediabetes presented impaired measurements of the median and minimum nocturnal oxygen saturation, the percentage of time spent with oxygen saturations below 90%, and the 4% oxygen desaturation index in comparison with individuals without prediabetes (p < 0.001 for all). After adjusting for age, sex, and the presence of obesity, HbA1c correlated with the HI in the entire population (r = 0.141, p < 0.001), and the presence of prediabetes was independently associated with the AHI (B = 2.20 (0.10 to 4.31), p = 0.040) as well as the HI (B = 1.87 (0.61 to 3.14), p = 0.004) in the multiple linear regression model. We conclude that prediabetes is an independent risk factor for an increased AHI after adjusting for age, sex, and obesity. The enhanced AHI is mainly associated with increments in the hypopnea events.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Clinical-Genetic Score for Predicting Weight Loss after Bariatric Surgery, The OBEGEN Study

  • Ciudin, Andreea|||0000-0001-5622-0203
  • Fidilio, Enzamaría
  • Gutiérrez-Carrasquilla, Liliana|||0000-0001-7809-3903
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Simó-Servat, Andreu|||0000-0002-1092-1327
  • Vilallonga, Ramon|||0000-0001-9333-2765
  • García Ruiz de Gordejuela, Amador|||0000-0002-0485-8536
  • de la Fuente, Maricruz
  • Luna, Alexis|||0000-0003-2351-5819
  • Sánchez, Enric|||0000-0001-7345-1601
  • Rigla Cros, Mercedes|||0000-0002-6691-4871
  • Hernández, Cristina|||0000-0002-3109-1721
  • Salas, Eduardo|||0000-0002-6837-2471
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Lecube, Albert|||0000-0001-9684-0183
Around 30% of the patients that undergo bariatric surgery (BS) do not reach an appropriate weight loss. The OBEGEN study aimed to assess the added value of genetic testing to clinical variables in predicting weight loss after BS. A multicenter, retrospective, longitudinal, and observational study including 416 patients who underwent BS was conducted (Clinical.Trials.gov- NCT02405949). 50 single nucleotide polymorphisms (SNPs) from 39 genes were examined. Receiver Operating Characteristic (ROC) curve analysis were used to calculate sensitivity and specificity. Satisfactory response to BS was defined as at nadir excess weight loss